Physician profile
Adrienne Reddick
NPI 1750997441
$1,307.89
in general payments reported to CMS, 2019-2025
21 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $215 · 2022: $101 · 2023: $833 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $991.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $140.56 | 2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Teva Pharmaceuticals USA, INC. | $132.43 | 2025 | Ajovy |
| Abbvie INC. | $131.52 | 2023 | |
| Amylyx Pharmaceuticals, INC. | $121.87 | 2023 | Relyvrio |
| Averitas Pharma INC. | $121.09 | 2023 | Qutenza |
| Mannkind Corporation | $103.99 | 2023 | Afrezza |
| Exact Sciences Corporation | $98.13 | 2023 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $81.04 | 2023 | Spravato |
| Organon LLC | $42.33 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.96 | 2021 | |
| Glaxosmithkline, LLC. | $37.69 | 2021-2022 | |
| Amgen INC. | $37.25 | 2021 | |
| Pfizer INC. | $35.24 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $34.76 | 2022 | |
| Corcept Therapeutics | $31.24 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $26.11 | 2025 | Vyloy |
| Amarin Pharma, INC. | $21.29 | 2021 | |
| Bioventus LLC | $20.36 | 2021 | |
| Dexcom, INC. | $18.70 | 2021 | |
| Merck Sharp & Dohme LLC | $17.59 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrienne Reddick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.